In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 25th, 2004 | 36 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.77 | 12.69 | -45.94 | 1 | 8 | 1 | 70 | 532.448 | 7 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 9.31e-03 g/l | DrugBank-approved |
Therapy | antifungal | SMDC MicroSource |
therap | antifungal, PXR/SRC1 & CAR/SRC1 inhibitor | MicroSource Spectrum |
UniProt Database Links | CP121_MYCTU; CP51_YEAST; ECM33_CANAL; FHN1_YEAST; MOD5_YEAST; PGA10_CANAL; PGA7_CANAL; QDR1_YEAST; RBT5_CANAL; RDS2_YEAST | ChEBI |
Patent Database Links | EP0862917; EP1229034; EP1438962; EP1514877; EP1588702; EP1611879; EP1632239; EP1634607; EP1637132; EP1639994; EP1645287; EP1685843; EP1712220; EP1738759; EP1829534; EP1839648; EP1842532; EP1857113; EP1864657; EP1886695; EP1894559; EP1895012; EP1923043; EP | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
C11B1-1-E | Cytochrome P450 11B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 135 | 0.27 | Binding ≤ 10μM |
CP11A-2-E | Cytochrome P450 11A1 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3920 | 0.21 | Binding ≤ 10μM |
CP17A-1-E | Cytochrome P450 17A1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2040 | 0.22 | Binding ≤ 10μM |
CP21A-1-E | Cytochrome P450 21 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6570 | 0.20 | Binding ≤ 10μM |
CP51A-1-E | Cytochrome P450 51 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1370 | 0.23 | Binding ≤ 10μM |
CP7A1-1-E | Cytochrome P450 7A1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1250 | 0.23 | Binding ≤ 10μM |
CP2A2-1-E | Cytochrome P450 2A2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 728 | 0.24 | ADME/T ≤ 10μM |
CP3A4-2-E | Cytochrome P450 3A4 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 897 | 0.24 | ADME/T ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
C11B1_BOVIN | P15150 | Cytochrome P450 11B1, Bovin | 135 | 0.27 | Binding ≤ 1μM |
CP11A_RAT | P14137 | Cytochrome P450 11A1, Rat | 3920 | 0.21 | Binding ≤ 10μM |
C11B1_BOVIN | P15150 | Cytochrome P450 11B1, Bovin | 135 | 0.27 | Binding ≤ 10μM |
CP17A_RAT | P11715 | Cytochrome P450 17A1, Rat | 2040 | 0.22 | Binding ≤ 10μM |
CP17A_HUMAN | P05093 | Cytochrome P450 17A1, Human | 2040 | 0.22 | Binding ≤ 10μM |
CP21A_HUMAN | P08686 | Cytochrome P450 21, Human | 6570 | 0.20 | Binding ≤ 10μM |
CP51A_RAT | Q64654 | Cytochrome P450 51, Rat | 1370 | 0.23 | Binding ≤ 10μM |
CP7A1_RAT | P18125 | Cytochrome P450 7A1, Rat | 1250 | 0.23 | Binding ≤ 10μM |
CP2A2_RAT | P15149 | Cytochrome P450 2A2, Rat | 728 | 0.24 | ADME/T ≤ 10μM |
CP3A4_HUMAN | P08684 | Cytochrome P450 3A4, Human | 897 | 0.24 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Activation of gene expression by SREBF (SREBP) | |
Aflatoxin activation and detoxification | |
Androgen biosynthesis | |
Cholesterol biosynthesis | |
Endogenous sterols | |
Glucocorticoid biosynthesis | |
Mineralocorticoid biosynthesis | |
PPARA activates gene expression | |
Pregnenolone biosynthesis | |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | |
Xenobiotics |